nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadobenate Dimeglumine—ALB—Erlotinib—pancreatic cancer	0.204	0.361	CbGbCtD
Gadobenate Dimeglumine—ALB—Irinotecan—pancreatic cancer	0.184	0.326	CbGbCtD
Gadobenate Dimeglumine—ALB—Fluorouracil—pancreatic cancer	0.177	0.313	CbGbCtD
Gadobenate Dimeglumine—Dizziness—Sunitinib—pancreatic cancer	0.000255	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000255	0.000587	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Irinotecan—pancreatic cancer	0.000251	0.000578	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Irinotecan—pancreatic cancer	0.000251	0.000578	CcSEcCtD
Gadobenate Dimeglumine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	0.000251	0.000578	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000251	0.000577	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Epirubicin—pancreatic cancer	0.000251	0.000577	CcSEcCtD
Gadobenate Dimeglumine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000249	0.000574	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Docetaxel—pancreatic cancer	0.000249	0.000572	CcSEcCtD
Gadobenate Dimeglumine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000246	0.000566	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Sunitinib—pancreatic cancer	0.000245	0.000564	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000245	0.000563	CcSEcCtD
Gadobenate Dimeglumine—Rash—Sunitinib—pancreatic cancer	0.000243	0.00056	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Sunitinib—pancreatic cancer	0.000243	0.000559	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Fluorouracil—pancreatic cancer	0.000242	0.000556	CcSEcCtD
Gadobenate Dimeglumine—Headache—Sunitinib—pancreatic cancer	0.000242	0.000556	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Docetaxel—pancreatic cancer	0.000241	0.000555	CcSEcCtD
Gadobenate Dimeglumine—Asthma—Doxorubicin—pancreatic cancer	0.000241	0.000555	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Docetaxel—pancreatic cancer	0.000241	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Epirubicin—pancreatic cancer	0.000241	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000241	0.000554	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Docetaxel—pancreatic cancer	0.000238	0.000547	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Docetaxel—pancreatic cancer	0.000237	0.000544	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000235	0.000541	CcSEcCtD
Gadobenate Dimeglumine—Cough—Docetaxel—pancreatic cancer	0.000235	0.00054	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000234	0.000539	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Docetaxel—pancreatic cancer	0.000232	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Epirubicin—pancreatic cancer	0.000232	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Epirubicin—pancreatic cancer	0.000232	0.000535	CcSEcCtD
Gadobenate Dimeglumine—Bronchitis—Doxorubicin—pancreatic cancer	0.000232	0.000533	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Docetaxel—pancreatic cancer	0.000229	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Docetaxel—pancreatic cancer	0.000229	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Docetaxel—pancreatic cancer	0.000229	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Sunitinib—pancreatic cancer	0.000229	0.000527	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Epirubicin—pancreatic cancer	0.000228	0.000525	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Irinotecan—pancreatic cancer	0.000228	0.000525	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000228	0.000524	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000226	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000226	0.00052	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000224	0.000516	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Docetaxel—pancreatic cancer	0.000224	0.000516	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Epirubicin—pancreatic cancer	0.000223	0.000512	CcSEcCtD
Gadobenate Dimeglumine—Pollakiuria—Doxorubicin—pancreatic cancer	0.000223	0.000512	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Gemcitabine—pancreatic cancer	0.000222	0.000511	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Epirubicin—pancreatic cancer	0.000221	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Docetaxel—pancreatic cancer	0.000221	0.00051	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Docetaxel—pancreatic cancer	0.00022	0.000505	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Gemcitabine—pancreatic cancer	0.000219	0.000504	CcSEcCtD
Gadobenate Dimeglumine—Infection—Docetaxel—pancreatic cancer	0.000218	0.000502	CcSEcCtD
Gadobenate Dimeglumine—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000217	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Irinotecan—pancreatic cancer	0.000217	0.0005	CcSEcCtD
Gadobenate Dimeglumine—Shock—Docetaxel—pancreatic cancer	0.000216	0.000497	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000215	0.000496	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Fluorouracil—pancreatic cancer	0.000215	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Infestation—Doxorubicin—pancreatic cancer	0.000215	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Infestation NOS—Doxorubicin—pancreatic cancer	0.000215	0.000495	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Docetaxel—pancreatic cancer	0.000214	0.000493	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Docetaxel—pancreatic cancer	0.000213	0.000491	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Epirubicin—pancreatic cancer	0.000212	0.000488	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000212	0.000487	CcSEcCtD
Gadobenate Dimeglumine—Renal failure—Doxorubicin—pancreatic cancer	0.000211	0.000486	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Irinotecan—pancreatic cancer	0.00021	0.000483	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Epirubicin—pancreatic cancer	0.000209	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000209	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000209	0.000481	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Fluorouracil—pancreatic cancer	0.000208	0.000479	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000207	0.000477	CcSEcCtD
Gadobenate Dimeglumine—Sweating—Doxorubicin—pancreatic cancer	0.000206	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Epirubicin—pancreatic cancer	0.000206	0.000474	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Epirubicin—pancreatic cancer	0.000205	0.000473	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Docetaxel—pancreatic cancer	0.000205	0.000472	CcSEcCtD
Gadobenate Dimeglumine—Haematuria—Doxorubicin—pancreatic cancer	0.000205	0.000472	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000205	0.000472	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Epirubicin—pancreatic cancer	0.000204	0.00047	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Irinotecan—pancreatic cancer	0.000202	0.000465	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Fluorouracil—pancreatic cancer	0.000201	0.000463	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Epirubicin—pancreatic cancer	0.000201	0.000462	CcSEcCtD
Gadobenate Dimeglumine—Rash—Irinotecan—pancreatic cancer	0.0002	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Irinotecan—pancreatic cancer	0.0002	0.000461	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.0002	0.00046	CcSEcCtD
Gadobenate Dimeglumine—Headache—Irinotecan—pancreatic cancer	0.000199	0.000458	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Docetaxel—pancreatic cancer	0.000197	0.000454	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Gemcitabine—pancreatic cancer	0.000197	0.000453	CcSEcCtD
Gadobenate Dimeglumine—Bradycardia—Doxorubicin—pancreatic cancer	0.000196	0.000452	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Docetaxel—pancreatic cancer	0.000196	0.000451	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Docetaxel—pancreatic cancer	0.000195	0.000449	CcSEcCtD
Gadobenate Dimeglumine—Rash—Gemcitabine—pancreatic cancer	0.000195	0.000449	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Gemcitabine—pancreatic cancer	0.000195	0.000449	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Epirubicin—pancreatic cancer	0.000195	0.000448	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Epirubicin—pancreatic cancer	0.000194	0.000447	CcSEcCtD
Gadobenate Dimeglumine—Headache—Gemcitabine—pancreatic cancer	0.000194	0.000446	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Epirubicin—pancreatic cancer	0.000194	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Epirubicin—pancreatic cancer	0.000194	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Fluorouracil—pancreatic cancer	0.000193	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Rhinitis—Doxorubicin—pancreatic cancer	0.000193	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Docetaxel—pancreatic cancer	0.000193	0.000445	CcSEcCtD
Gadobenate Dimeglumine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000192	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Rash—Fluorouracil—pancreatic cancer	0.000192	0.000442	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Fluorouracil—pancreatic cancer	0.000192	0.000441	CcSEcCtD
Gadobenate Dimeglumine—Headache—Fluorouracil—pancreatic cancer	0.000191	0.000439	CcSEcCtD
Gadobenate Dimeglumine—Urinary tract disorder—Doxorubicin—pancreatic cancer	0.000191	0.000438	CcSEcCtD
Gadobenate Dimeglumine—Oedema peripheral—Doxorubicin—pancreatic cancer	0.00019	0.000437	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.00019	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.00019	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Docetaxel—pancreatic cancer	0.000189	0.000436	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Epirubicin—pancreatic cancer	0.000189	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Urethral disorder—Doxorubicin—pancreatic cancer	0.000189	0.000435	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Irinotecan—pancreatic cancer	0.000189	0.000434	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Epirubicin—pancreatic cancer	0.000188	0.000433	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.000188	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Pain—Docetaxel—pancreatic cancer	0.000188	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Docetaxel—pancreatic cancer	0.000188	0.000432	CcSEcCtD
Gadobenate Dimeglumine—Chills—Epirubicin—pancreatic cancer	0.000187	0.000431	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Epirubicin—pancreatic cancer	0.000186	0.000429	CcSEcCtD
Gadobenate Dimeglumine—Visual impairment—Doxorubicin—pancreatic cancer	0.000186	0.000428	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Gemcitabine—pancreatic cancer	0.000184	0.000423	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Epirubicin—pancreatic cancer	0.000183	0.00042	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Epirubicin—pancreatic cancer	0.000182	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Epirubicin—pancreatic cancer	0.000182	0.000418	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Docetaxel—pancreatic cancer	0.000181	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Fluorouracil—pancreatic cancer	0.000181	0.000416	CcSEcCtD
Gadobenate Dimeglumine—Eye disorder—Doxorubicin—pancreatic cancer	0.00018	0.000415	CcSEcCtD
Gadobenate Dimeglumine—Tinnitus—Doxorubicin—pancreatic cancer	0.00018	0.000414	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00018	0.000413	CcSEcCtD
Gadobenate Dimeglumine—Flushing—Doxorubicin—pancreatic cancer	0.000179	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Cardiac disorder—Doxorubicin—pancreatic cancer	0.000179	0.000412	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Epirubicin—pancreatic cancer	0.000178	0.000409	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Epirubicin—pancreatic cancer	0.000176	0.000404	CcSEcCtD
Gadobenate Dimeglumine—Angiopathy—Doxorubicin—pancreatic cancer	0.000175	0.000403	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Epirubicin—pancreatic cancer	0.000175	0.000402	CcSEcCtD
Gadobenate Dimeglumine—Immune system disorder—Doxorubicin—pancreatic cancer	0.000174	0.000401	CcSEcCtD
Gadobenate Dimeglumine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000174	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Docetaxel—pancreatic cancer	0.000174	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Docetaxel—pancreatic cancer	0.000174	0.0004	CcSEcCtD
Gadobenate Dimeglumine—Chills—Doxorubicin—pancreatic cancer	0.000173	0.000398	CcSEcCtD
Gadobenate Dimeglumine—Arrhythmia—Doxorubicin—pancreatic cancer	0.000172	0.000397	CcSEcCtD
Gadobenate Dimeglumine—Mental disorder—Doxorubicin—pancreatic cancer	0.000169	0.000389	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000168	0.000388	CcSEcCtD
Gadobenate Dimeglumine—Erythema—Doxorubicin—pancreatic cancer	0.000168	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Malnutrition—Doxorubicin—pancreatic cancer	0.000168	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Epirubicin—pancreatic cancer	0.000168	0.000386	CcSEcCtD
Gadobenate Dimeglumine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000164	0.000378	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Epirubicin—pancreatic cancer	0.000164	0.000377	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Epirubicin—pancreatic cancer	0.000163	0.000375	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Epirubicin—pancreatic cancer	0.000162	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Back pain—Doxorubicin—pancreatic cancer	0.000162	0.000374	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000162	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000161	0.000372	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Epirubicin—pancreatic cancer	0.00016	0.000369	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Epirubicin—pancreatic cancer	0.00016	0.000367	CcSEcCtD
Gadobenate Dimeglumine—Cough—Epirubicin—pancreatic cancer	0.000158	0.000364	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Docetaxel—pancreatic cancer	0.000158	0.000363	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Epirubicin—pancreatic cancer	0.000157	0.000361	CcSEcCtD
Gadobenate Dimeglumine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000156	0.000359	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Docetaxel—pancreatic cancer	0.000155	0.000358	CcSEcCtD
Gadobenate Dimeglumine—Anaemia—Doxorubicin—pancreatic cancer	0.000155	0.000357	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Epirubicin—pancreatic cancer	0.000155	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Epirubicin—pancreatic cancer	0.000155	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Epirubicin—pancreatic cancer	0.000155	0.000356	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Epirubicin—pancreatic cancer	0.000154	0.000354	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000153	0.000353	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Epirubicin—pancreatic cancer	0.000153	0.000351	CcSEcCtD
Gadobenate Dimeglumine—Malaise—Doxorubicin—pancreatic cancer	0.000151	0.000349	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Epirubicin—pancreatic cancer	0.000151	0.000348	CcSEcCtD
Gadobenate Dimeglumine—Syncope—Doxorubicin—pancreatic cancer	0.000151	0.000347	CcSEcCtD
Gadobenate Dimeglumine—Leukopenia—Doxorubicin—pancreatic cancer	0.00015	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Docetaxel—pancreatic cancer	0.00015	0.000346	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Epirubicin—pancreatic cancer	0.000149	0.000344	CcSEcCtD
Gadobenate Dimeglumine—Palpitations—Doxorubicin—pancreatic cancer	0.000148	0.000342	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000148	0.000341	CcSEcCtD
Gadobenate Dimeglumine—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000148	0.00034	CcSEcCtD
Gadobenate Dimeglumine—Infection—Epirubicin—pancreatic cancer	0.000147	0.000339	CcSEcCtD
Gadobenate Dimeglumine—Cough—Doxorubicin—pancreatic cancer	0.000147	0.000337	CcSEcCtD
Gadobenate Dimeglumine—Shock—Epirubicin—pancreatic cancer	0.000146	0.000335	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000145	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Docetaxel—pancreatic cancer	0.000145	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Hypertension—Doxorubicin—pancreatic cancer	0.000145	0.000334	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Epirubicin—pancreatic cancer	0.000145	0.000333	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Epirubicin—pancreatic cancer	0.000144	0.000331	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000143	0.00033	CcSEcCtD
Gadobenate Dimeglumine—Arthralgia—Doxorubicin—pancreatic cancer	0.000143	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Myalgia—Doxorubicin—pancreatic cancer	0.000143	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Chest pain—Doxorubicin—pancreatic cancer	0.000143	0.000329	CcSEcCtD
Gadobenate Dimeglumine—Anxiety—Doxorubicin—pancreatic cancer	0.000143	0.000328	CcSEcCtD
Gadobenate Dimeglumine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000142	0.000327	CcSEcCtD
Gadobenate Dimeglumine—Discomfort—Doxorubicin—pancreatic cancer	0.000141	0.000325	CcSEcCtD
Gadobenate Dimeglumine—Dry mouth—Doxorubicin—pancreatic cancer	0.00014	0.000322	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Docetaxel—pancreatic cancer	0.00014	0.000321	CcSEcCtD
Gadobenate Dimeglumine—Rash—Docetaxel—pancreatic cancer	0.000138	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Epirubicin—pancreatic cancer	0.000138	0.000319	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Docetaxel—pancreatic cancer	0.000138	0.000318	CcSEcCtD
Gadobenate Dimeglumine—Confusional state—Doxorubicin—pancreatic cancer	0.000138	0.000318	CcSEcCtD
Gadobenate Dimeglumine—Headache—Docetaxel—pancreatic cancer	0.000138	0.000317	CcSEcCtD
Gadobenate Dimeglumine—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000137	0.000315	CcSEcCtD
Gadobenate Dimeglumine—Infection—Doxorubicin—pancreatic cancer	0.000136	0.000313	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.000135	0.000311	CcSEcCtD
Gadobenate Dimeglumine—Shock—Doxorubicin—pancreatic cancer	0.000135	0.00031	CcSEcCtD
Gadobenate Dimeglumine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.000134	0.000309	CcSEcCtD
Gadobenate Dimeglumine—Tachycardia—Doxorubicin—pancreatic cancer	0.000134	0.000308	CcSEcCtD
Gadobenate Dimeglumine—Skin disorder—Doxorubicin—pancreatic cancer	0.000133	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Epirubicin—pancreatic cancer	0.000133	0.000306	CcSEcCtD
Gadobenate Dimeglumine—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000133	0.000305	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Epirubicin—pancreatic cancer	0.000132	0.000304	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Epirubicin—pancreatic cancer	0.000132	0.000303	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Docetaxel—pancreatic cancer	0.00013	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Epirubicin—pancreatic cancer	0.00013	0.0003	CcSEcCtD
Gadobenate Dimeglumine—Hypotension—Doxorubicin—pancreatic cancer	0.000128	0.000295	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000128	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Epirubicin—pancreatic cancer	0.000128	0.000294	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Epirubicin—pancreatic cancer	0.000127	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Pain—Epirubicin—pancreatic cancer	0.000127	0.000292	CcSEcCtD
Gadobenate Dimeglumine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000125	0.000287	CcSEcCtD
Gadobenate Dimeglumine—Paraesthesia—Doxorubicin—pancreatic cancer	0.000123	0.000283	CcSEcCtD
Gadobenate Dimeglumine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000122	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000122	0.000281	CcSEcCtD
Gadobenate Dimeglumine—Somnolence—Doxorubicin—pancreatic cancer	0.000122	0.00028	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000121	0.000279	CcSEcCtD
Gadobenate Dimeglumine—Dyspepsia—Doxorubicin—pancreatic cancer	0.000121	0.000278	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000118	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Fatigue—Doxorubicin—pancreatic cancer	0.000118	0.000272	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Epirubicin—pancreatic cancer	0.000118	0.000271	CcSEcCtD
Gadobenate Dimeglumine—Constipation—Doxorubicin—pancreatic cancer	0.000117	0.00027	CcSEcCtD
Gadobenate Dimeglumine—Pain—Doxorubicin—pancreatic cancer	0.000117	0.00027	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Epirubicin—pancreatic cancer	0.000117	0.000269	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Epirubicin—pancreatic cancer	0.000117	0.000269	CcSEcCtD
Gadobenate Dimeglumine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000113	0.00026	CcSEcCtD
Gadobenate Dimeglumine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000112	0.000258	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000109	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Urticaria—Doxorubicin—pancreatic cancer	0.000109	0.000251	CcSEcCtD
Gadobenate Dimeglumine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000108	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000108	0.000249	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Epirubicin—pancreatic cancer	0.000106	0.000245	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Epirubicin—pancreatic cancer	0.000105	0.000241	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Epirubicin—pancreatic cancer	0.000101	0.000233	CcSEcCtD
Gadobenate Dimeglumine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.000101	0.000232	CcSEcCtD
Gadobenate Dimeglumine—Asthenia—Doxorubicin—pancreatic cancer	9.84e-05	0.000226	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Epirubicin—pancreatic cancer	9.8e-05	0.000225	CcSEcCtD
Gadobenate Dimeglumine—Pruritus—Doxorubicin—pancreatic cancer	9.7e-05	0.000223	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Epirubicin—pancreatic cancer	9.42e-05	0.000217	CcSEcCtD
Gadobenate Dimeglumine—Diarrhoea—Doxorubicin—pancreatic cancer	9.38e-05	0.000216	CcSEcCtD
Gadobenate Dimeglumine—Rash—Epirubicin—pancreatic cancer	9.34e-05	0.000215	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Epirubicin—pancreatic cancer	9.33e-05	0.000215	CcSEcCtD
Gadobenate Dimeglumine—Headache—Epirubicin—pancreatic cancer	9.28e-05	0.000214	CcSEcCtD
Gadobenate Dimeglumine—Dizziness—Doxorubicin—pancreatic cancer	9.07e-05	0.000209	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Epirubicin—pancreatic cancer	8.8e-05	0.000202	CcSEcCtD
Gadobenate Dimeglumine—Vomiting—Doxorubicin—pancreatic cancer	8.72e-05	0.000201	CcSEcCtD
Gadobenate Dimeglumine—Rash—Doxorubicin—pancreatic cancer	8.64e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Dermatitis—Doxorubicin—pancreatic cancer	8.64e-05	0.000199	CcSEcCtD
Gadobenate Dimeglumine—Headache—Doxorubicin—pancreatic cancer	8.59e-05	0.000198	CcSEcCtD
Gadobenate Dimeglumine—Nausea—Doxorubicin—pancreatic cancer	8.14e-05	0.000187	CcSEcCtD
